chrX-50607728-TTCC-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP3BP6_Very_StrongBS2

The NM_020717.5(SHROOM4):​c.3411_3413delGGA​(p.Glu1138del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000299 in 1,111,158 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 64 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00043 ( 0 hom., 10 hem., cov: 14)
Exomes 𝑓: 0.00029 ( 0 hom. 54 hem. )

Consequence

SHROOM4
NM_020717.5 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.943

Publications

9 publications found
Variant links:
Genes affected
SHROOM4 (HGNC:29215): (shroom family member 4) This gene encodes a member of the APX/Shroom family, which contain an N-terminal PDZ domain and a C-terminal ASD2 motif. The encoded protein may play a role in cytoskeletal architecture. Mutations in this gene have been linked to the X-linked Stocco dos Santos syndrome characterized by cognitive disabilities. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2017]
SHROOM4 Gene-Disease associations (from GenCC):
  • X-linked intellectual disability, Stocco dos Santos type
    Inheritance: XL Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • complex neurodevelopmental disorder
    Inheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_020717.5
BP6
Variant X-50607728-TTCC-T is Benign according to our data. Variant chrX-50607728-TTCC-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 590248.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 10 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SHROOM4NM_020717.5 linkc.3411_3413delGGA p.Glu1138del disruptive_inframe_deletion Exon 6 of 9 ENST00000376020.9 NP_065768.2 Q9ULL8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SHROOM4ENST00000376020.9 linkc.3411_3413delGGA p.Glu1138del disruptive_inframe_deletion Exon 6 of 9 2 NM_020717.5 ENSP00000365188.2 Q9ULL8-1
SHROOM4ENST00000289292.11 linkc.3411_3413delGGA p.Glu1138del disruptive_inframe_deletion Exon 6 of 10 1 ENSP00000289292.7 Q9ULL8-1
SHROOM4ENST00000460112.3 linkc.3063_3065delGGA p.Glu1022del disruptive_inframe_deletion Exon 5 of 8 5 ENSP00000421450.1 Q9ULL8-2

Frequencies

GnomAD3 genomes
AF:
0.000426
AC:
45
AN:
105667
Hom.:
0
Cov.:
14
show subpopulations
Gnomad AFR
AF:
0.000388
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000605
Gnomad ASJ
AF:
0.00234
Gnomad EAS
AF:
0.00178
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00431
Gnomad NFE
AF:
0.000272
Gnomad OTH
AF:
0.000717
GnomAD2 exomes
AF:
0.000598
AC:
76
AN:
127114
AF XY:
0.000184
show subpopulations
Gnomad AFR exome
AF:
0.000335
Gnomad AMR exome
AF:
0.000547
Gnomad ASJ exome
AF:
0.00257
Gnomad EAS exome
AF:
0.00103
Gnomad FIN exome
AF:
0.000166
Gnomad NFE exome
AF:
0.000539
Gnomad OTH exome
AF:
0.000926
GnomAD4 exome
AF:
0.000285
AC:
287
AN:
1005455
Hom.:
0
AF XY:
0.000179
AC XY:
54
AN XY:
301399
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000413
AC:
10
AN:
24226
American (AMR)
AF:
0.000397
AC:
13
AN:
32777
Ashkenazi Jewish (ASJ)
AF:
0.00221
AC:
39
AN:
17680
East Asian (EAS)
AF:
0.000414
AC:
12
AN:
29002
South Asian (SAS)
AF:
0.000414
AC:
19
AN:
45849
European-Finnish (FIN)
AF:
0.000156
AC:
6
AN:
38470
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3673
European-Non Finnish (NFE)
AF:
0.000228
AC:
176
AN:
771191
Other (OTH)
AF:
0.000282
AC:
12
AN:
42587
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.371
Heterozygous variant carriers
0
18
35
53
70
88
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000426
AC:
45
AN:
105703
Hom.:
0
Cov.:
14
AF XY:
0.000348
AC XY:
10
AN XY:
28729
show subpopulations
African (AFR)
AF:
0.000387
AC:
11
AN:
28415
American (AMR)
AF:
0.000604
AC:
6
AN:
9934
Ashkenazi Jewish (ASJ)
AF:
0.00234
AC:
6
AN:
2565
East Asian (EAS)
AF:
0.00179
AC:
6
AN:
3358
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5425
Middle Eastern (MID)
AF:
0.00474
AC:
1
AN:
211
European-Non Finnish (NFE)
AF:
0.000272
AC:
14
AN:
51470
Other (OTH)
AF:
0.000708
AC:
1
AN:
1412
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.524
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00292
Hom.:
966

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Nov 10, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

SHROOM4-related disorder Benign:1
Mar 01, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SHROOM4: BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.94
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143151534; hg19: chrX-50350728; COSMIC: COSV108785678; API